A detailed history of Wells Fargo & Company transactions in X Biotech Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 155 shares of XBIT stock, worth $925. This represents 0.0% of its overall portfolio holdings.

Number of Shares
155
Previous 152 1.97%
Holding current value
$925
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$4.03 - $8.13 $12 - $24
3 Added 1.97%
155 $1,000
Q4 2023

Feb 09, 2024

BUY
$3.56 - $4.65 $28 - $37
8 Added 5.56%
152 $0
Q3 2023

Nov 13, 2023

BUY
$4.02 - $5.81 $68 - $98
17 Added 13.39%
144 $0
Q2 2023

Aug 15, 2023

BUY
$3.06 - $6.38 $15 - $31
5 Added 4.1%
127 $0
Q1 2023

May 12, 2023

BUY
$3.22 - $4.72 $6 - $9
2 Added 1.67%
122 $0
Q4 2022

Feb 13, 2023

BUY
$3.03 - $3.64 $9 - $10
3 Added 2.56%
120 $0
Q3 2022

Nov 14, 2022

BUY
$3.72 - $5.88 $55 - $88
15 Added 14.71%
117 $0
Q2 2022

Aug 12, 2022

SELL
$5.13 - $9.2 $107,796 - $193,319
-21,013 Reduced 99.52%
102 $1,000
Q1 2022

May 16, 2022

SELL
$8.64 - $11.71 $139,682 - $189,315
-16,167 Reduced 43.36%
21,115 $182,000
Q4 2021

Feb 14, 2022

SELL
$10.95 - $16.07 $1.21 Million - $1.77 Million
-110,165 Reduced 74.71%
37,282 $415,000
Q3 2021

Nov 15, 2021

SELL
$12.95 - $18.24 $816,329 - $1.15 Million
-63,037 Reduced 29.95%
147,447 $1.91 Million
Q2 2021

Aug 16, 2021

SELL
$15.83 - $17.84 $269,632 - $303,868
-17,033 Reduced 7.49%
210,484 $3.49 Million
Q1 2021

May 13, 2021

BUY
$15.92 - $20.3 $1.81 Million - $2.3 Million
113,382 Added 99.34%
227,517 $3.91 Million
Q4 2020

Feb 09, 2021

BUY
$15.65 - $19.92 $654,185 - $832,675
41,801 Added 57.79%
114,135 $1.79 Million
Q3 2020

Nov 05, 2020

BUY
$13.97 - $21.16 $200,301 - $303,392
14,338 Added 24.72%
72,334 $1.38 Million
Q2 2020

Aug 13, 2020

BUY
$10.39 - $16.07 $461,991 - $714,552
44,465 Added 328.62%
57,996 $795,000
Q1 2020

May 14, 2020

BUY
$8.89 - $24.94 $120,290 - $337,463
13,531 New
13,531 $144,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $182M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.